Share Price and Basic Stock Data
Last Updated: February 9, 2026, 9:37 pm
| PEG Ratio | 4.39 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Usha Martin Ltd, operating in the steel alloys and special steel sector, reported a market capitalization of ₹12,107 Cr and a share price of ₹397. The company has shown a solid revenue trajectory, with sales increasing from ₹2,688 Cr in FY 2022 to ₹3,268 Cr in FY 2023. The trailing twelve months (TTM) revenue stood at ₹3,551 Cr. Quarterly sales figures reveal fluctuations, with the highest recorded at ₹855 Cr in March 2023, while the latest quarter (September 2023) reported sales of ₹785 Cr. The company has experienced a general upward trend in sales over the years, although some quarters indicated slight declines, reflecting typical seasonality in the steel industry. The operational performance has also been bolstered by a rise in sales volume and pricing power, indicating a favorable market environment for Usha Martin.
Profitability and Efficiency Metrics
Usha Martin’s profitability metrics illustrate a robust operational framework, with a reported operating profit margin (OPM) of 19% and a net profit of ₹404 Cr. The OPM has seen fluctuations, peaking at 20% in December 2023, indicative of effective cost management strategies. The company’s return on equity (ROE) stood at 15.8%, while return on capital employed (ROCE) was recorded at 18.8%, both reflecting efficient use of capital. The interest coverage ratio (ICR) of 21.54x indicates a strong ability to meet interest obligations, suggesting financial stability. However, the cash conversion cycle (CCC) of 205 days highlights potential inefficiencies in inventory management and receivable collection, which could be improved to enhance cash flow and operational efficiency.
Balance Sheet Strength and Financial Ratios
Usha Martin’s balance sheet demonstrates a healthy financial structure, with total borrowings declining to ₹264 Cr, significantly lower than historical levels. The company’s reserves have increased to ₹2,934 Cr, indicating a strong retained earnings position. The debt-to-equity ratio stands at a manageable 0.12, reflecting a conservative approach to leverage. Financial ratios such as the current ratio of 2.85 and quick ratio of 1.44 suggest strong liquidity and the ability to cover short-term liabilities. Furthermore, the price-to-book value (P/BV) ratio of 3.73x indicates that the stock is trading at a premium, often seen in companies with strong growth prospects. However, the company must remain vigilant regarding its cash conversion cycle, which could impact liquidity if not addressed.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Usha Martin reveals a diverse ownership structure, with promoters holding 41.75% of shares, a decline from 48.30% in December 2022. Foreign institutional investors (FIIs) have increased their stake to 14.14%, while domestic institutional investors (DIIs) hold 12.29%. The public shareholding stands at 31.74%, reflecting a healthy level of retail investor participation. The increasing interest from FIIs and DIIs could indicate growing confidence in the company’s future prospects. The number of shareholders rose to 1,04,821, suggesting enhanced retail interest. However, the declining promoter stake may raise concerns about long-term commitment and governance, which could impact investor sentiment if not managed properly.
Outlook, Risks, and Final Insight
Looking ahead, Usha Martin’s outlook appears cautiously optimistic, bolstered by solid operational performance and a strengthening balance sheet. However, risks such as fluctuations in raw material costs and global steel demand could impact profitability. Additionally, the company’s relatively high cash conversion cycle poses a challenge to operational efficiency, necessitating improved inventory and receivables management. The steel industry is also subject to regulatory changes and environmental scrutiny, which could impose additional costs. Should Usha Martin successfully enhance its operational efficiencies and maintain its market position, it can leverage growth opportunities in a recovering global economy. Conversely, failure to address these risks may hinder its ability to sustain growth and profitability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Elango Industries Ltd | 3.14 Cr. | 8.23 | 16.1/7.84 | 9.72 | 0.00 % | 5.67 % | 5.67 % | 10.0 | |
| Ashnisha Industries Ltd | 94.6 Cr. | 3.57 | 4.94/2.57 | 326 | 2.30 | 0.00 % | 1.23 % | 0.28 % | 1.00 |
| Usha Martin Ltd | 13,307 Cr. | 437 | 498/279 | 29.7 | 97.3 | 0.69 % | 18.8 % | 15.8 % | 1.00 |
| Shah Alloys Ltd | 130 Cr. | 65.9 | 83.8/43.3 | 5.18 | 0.00 % | 25.8 % | 1,108 % | 10.0 | |
| Mukand Ltd | 1,881 Cr. | 130 | 162/84.4 | 29.1 | 66.3 | 1.54 % | 9.91 % | 7.84 % | 10.0 |
| Industry Average | 20,122.25 Cr | 239.12 | 101.70 | 66.63 | 0.44% | 13.27% | 192.30% | 5.67 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 834 | 855 | 814 | 785 | 797 | 829 | 826 | 891 | 861 | 896 | 887 | 908 | 917 |
| Expenses | 707 | 701 | 669 | 640 | 640 | 678 | 672 | 730 | 718 | 757 | 743 | 735 | 741 |
| Operating Profit | 127 | 154 | 146 | 144 | 157 | 152 | 154 | 161 | 143 | 140 | 145 | 173 | 176 |
| OPM % | 15% | 18% | 18% | 18% | 20% | 18% | 19% | 18% | 17% | 16% | 16% | 19% | 19% |
| Other Income | 7 | 13 | 7 | 25 | 8 | 14 | 9 | 11 | 9 | 28 | 20 | 10 | -5 |
| Interest | 8 | 8 | 6 | 6 | 6 | 7 | 7 | 8 | 9 | 7 | 6 | 5 | 5 |
| Depreciation | 17 | 17 | 18 | 18 | 19 | 23 | 22 | 23 | 26 | 28 | 29 | 28 | 29 |
| Profit before tax | 110 | 142 | 129 | 144 | 140 | 136 | 135 | 141 | 118 | 133 | 130 | 150 | 138 |
| Tax % | 23% | 26% | 22% | 24% | 23% | 22% | 23% | 23% | 22% | 24% | 22% | 27% | 22% |
| Net Profit | 84 | 105 | 101 | 110 | 108 | 106 | 104 | 109 | 92 | 101 | 101 | 110 | 108 |
| EPS in Rs | 2.75 | 3.45 | 3.31 | 3.59 | 3.53 | 3.49 | 3.42 | 3.60 | 3.04 | 3.31 | 3.31 | 3.60 | 3.53 |
Last Updated: February 3, 2026, 5:16 pm
Below is a detailed analysis of the quarterly data for Usha Martin Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 917.00 Cr.. The value appears strong and on an upward trend. It has increased from 908.00 Cr. (Sep 2025) to 917.00 Cr., marking an increase of 9.00 Cr..
- For Expenses, as of Dec 2025, the value is 741.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 735.00 Cr. (Sep 2025) to 741.00 Cr., marking an increase of 6.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 176.00 Cr.. The value appears strong and on an upward trend. It has increased from 173.00 Cr. (Sep 2025) to 176.00 Cr., marking an increase of 3.00 Cr..
- For OPM %, as of Dec 2025, the value is 19.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 19.00%.
- For Other Income, as of Dec 2025, the value is -5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10.00 Cr. (Sep 2025) to -5.00 Cr., marking a decrease of 15.00 Cr..
- For Interest, as of Dec 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 5.00 Cr..
- For Depreciation, as of Dec 2025, the value is 29.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.00 Cr. (Sep 2025) to 29.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 138.00 Cr.. The value appears to be declining and may need further review. It has decreased from 150.00 Cr. (Sep 2025) to 138.00 Cr., marking a decrease of 12.00 Cr..
- For Tax %, as of Dec 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Sep 2025) to 22.00%, marking a decrease of 5.00%.
- For Net Profit, as of Dec 2025, the value is 108.00 Cr.. The value appears to be declining and may need further review. It has decreased from 110.00 Cr. (Sep 2025) to 108.00 Cr., marking a decrease of 2.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 3.53. The value appears to be declining and may need further review. It has decreased from 3.60 (Sep 2025) to 3.53, marking a decrease of 0.07.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:26 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,074 | 4,561 | 4,112 | 3,882 | 2,066 | 2,488 | 2,154 | 2,097 | 2,688 | 3,268 | 3,225 | 3,474 | 3,551 |
| Expenses | 3,357 | 3,845 | 3,771 | 3,493 | 2,253 | 2,512 | 1,922 | 1,818 | 2,304 | 2,754 | 2,627 | 2,877 | 2,952 |
| Operating Profit | 717 | 717 | 341 | 389 | -188 | -24 | 232 | 279 | 384 | 513 | 599 | 597 | 600 |
| OPM % | 18% | 16% | 8% | 10% | -9% | -1% | 11% | 13% | 14% | 16% | 19% | 17% | 17% |
| Other Income | 82 | -63 | 32 | 120 | 77 | 17 | 537 | 29 | 75 | 40 | 53 | 57 | 67 |
| Interest | 440 | 522 | 547 | 564 | 92 | 114 | 74 | 57 | 42 | 30 | 25 | 30 | 27 |
| Depreciation | 333 | 418 | 308 | 300 | 60 | 61 | 64 | 68 | 70 | 67 | 77 | 98 | 110 |
| Profit before tax | 27 | -287 | -481 | -355 | -264 | -181 | 630 | 183 | 346 | 455 | 550 | 527 | 530 |
| Tax % | 50% | -12% | -11% | 1% | 2% | -126% | 33% | 20% | 16% | 23% | 23% | 23% | |
| Net Profit | 13 | -251 | -428 | -358 | -268 | 49 | 421 | 152 | 291 | 351 | 424 | 406 | 404 |
| EPS in Rs | 0.35 | -8.31 | -14.10 | -11.78 | -8.90 | 1.57 | 13.74 | 4.91 | 9.56 | 11.49 | 13.91 | 13.37 | 13.26 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 21% | 22% | 20% | 22% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -2030.77% | -70.52% | 16.36% | 25.14% | 118.28% | 759.18% | -63.90% | 91.45% | 20.62% | 20.80% | -4.25% |
| Change in YoY Net Profit Growth (%) | 0.00% | 1960.25% | 86.87% | 8.78% | 93.14% | 640.90% | -823.08% | 155.34% | -70.83% | 0.18% | -25.04% |
Usha Martin Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 0% |
| 3 Years: | 15% |
| TTM: | -5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 39% |
| 5 Years: | 69% |
| 3 Years: | 38% |
| 1 Year: | 12% |
| Return on Equity | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 17% |
| 3 Years: | 18% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 4, 2025, 2:10 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
| Reserves | 1,972 | 1,728 | 1,323 | 914 | 697 | 751 | 1,197 | 1,373 | 1,663 | 2,000 | 2,349 | 2,721 | 2,934 |
| Borrowings | 3,732 | 3,993 | 4,472 | 4,364 | 4,073 | 3,565 | 620 | 530 | 411 | 417 | 364 | 417 | 264 |
| Other Liabilities | 2,914 | 2,556 | 2,111 | 2,423 | 2,646 | 2,645 | 696 | 649 | 625 | 627 | 570 | 563 | 624 |
| Total Liabilities | 8,649 | 8,307 | 7,936 | 7,731 | 7,445 | 6,992 | 2,544 | 2,582 | 2,730 | 3,075 | 3,313 | 3,731 | 3,854 |
| Fixed Assets | 5,500 | 5,477 | 5,302 | 5,031 | 4,862 | 935 | 956 | 932 | 913 | 952 | 1,153 | 1,406 | 1,461 |
| CWIP | 373 | 132 | 147 | 121 | 113 | 13 | 33 | 45 | 38 | 139 | 166 | 118 | 177 |
| Investments | 0 | 0 | 46 | 37 | 39 | 42 | 44 | 48 | 56 | 66 | 56 | 68 | 70 |
| Other Assets | 2,775 | 2,698 | 2,441 | 2,542 | 2,432 | 6,001 | 1,511 | 1,557 | 1,722 | 1,917 | 1,938 | 2,140 | 2,146 |
| Total Assets | 8,649 | 8,307 | 7,936 | 7,731 | 7,445 | 6,992 | 2,544 | 2,582 | 2,730 | 3,075 | 3,313 | 3,731 | 3,854 |
Below is a detailed analysis of the balance sheet data for Usha Martin Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 31.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 31.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,934.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,721.00 Cr. (Mar 2025) to 2,934.00 Cr., marking an increase of 213.00 Cr..
- For Borrowings, as of Sep 2025, the value is 264.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 417.00 Cr. (Mar 2025) to 264.00 Cr., marking a decrease of 153.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 624.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 563.00 Cr. (Mar 2025) to 624.00 Cr., marking an increase of 61.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,854.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,731.00 Cr. (Mar 2025) to 3,854.00 Cr., marking an increase of 123.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,461.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,406.00 Cr. (Mar 2025) to 1,461.00 Cr., marking an increase of 55.00 Cr..
- For CWIP, as of Sep 2025, the value is 177.00 Cr.. The value appears strong and on an upward trend. It has increased from 118.00 Cr. (Mar 2025) to 177.00 Cr., marking an increase of 59.00 Cr..
- For Investments, as of Sep 2025, the value is 70.00 Cr.. The value appears strong and on an upward trend. It has increased from 68.00 Cr. (Mar 2025) to 70.00 Cr., marking an increase of 2.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,146.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,140.00 Cr. (Mar 2025) to 2,146.00 Cr., marking an increase of 6.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,854.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,731.00 Cr. (Mar 2025) to 3,854.00 Cr., marking an increase of 123.00 Cr..
Notably, the Reserves (2,934.00 Cr.) exceed the Borrowings (264.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 714.00 | 714.00 | 337.00 | 385.00 | -192.00 | -27.00 | -388.00 | -251.00 | -27.00 | 96.00 | 235.00 | 180.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 39 | 55 | 64 | 119 | 48 | 51 | 57 | 56 | 56 | 61 | 55 |
| Inventory Days | 400 | 378 | 241 | 261 | 350 | 156 | 183 | 209 | 196 | 180 | 199 | 205 |
| Days Payable | 429 | 397 | 288 | 362 | 561 | 78 | 108 | 113 | 72 | 60 | 56 | 56 |
| Cash Conversion Cycle | 18 | 20 | 7 | -37 | -92 | 126 | 126 | 153 | 180 | 175 | 204 | 205 |
| Working Capital Days | -104 | -79 | -96 | -138 | -288 | -106 | 56 | 78 | 98 | 98 | 114 | 107 |
| ROCE % | 9% | 6% | 1% | 3% | -4% | -1% | 22% | 13% | 18% | 21% | 22% | 19% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Tata Small Cap Fund | 11,003,695 | 4.41 | 499.57 | 10,981,660 | 2026-01-26 03:43:04 | 0.2% |
| Quant Small Cap Fund | 10,716,104 | 1.63 | 486.51 | 6,919,321 | 2025-11-02 19:42:14 | 54.87% |
| ICICI Prudential Commodities Fund | 3,138,006 | 4.18 | 142.47 | N/A | N/A | N/A |
| Mahindra Manulife Small Cap Fund | 2,271,287 | 2.44 | 103.12 | 1,819,918 | 2026-01-26 03:43:04 | 24.8% |
| ICICI Prudential Manufacturing Fund | 1,781,054 | 1.23 | 80.86 | N/A | N/A | N/A |
| Bandhan Large & Mid Cap Fund | 1,595,115 | 0.53 | 72.42 | 1,217,346 | 2026-01-26 03:43:04 | 31.03% |
| Bandhan Small Cap Fund | 1,230,714 | 0.29 | 55.87 | 615,648 | 2026-01-26 03:43:04 | 99.91% |
| Tata Multicap Fund | 920,000 | 1.3 | 41.77 | N/A | N/A | N/A |
| ICICI Prudential Retirement Fund - Pure Equity | 857,275 | 2.37 | 38.92 | N/A | N/A | N/A |
| Quant Multi Cap Fund | 698,546 | 0.39 | 31.71 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 13.37 | 13.92 | 11.51 | 9.56 | 4.91 |
| Diluted EPS (Rs.) | 13.37 | 13.92 | 11.51 | 9.56 | 4.91 |
| Cash EPS (Rs.) | 15.94 | 16.00 | 13.31 | 11.55 | 7.03 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 90.17 | 78.06 | 66.64 | 55.58 | 46.07 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 90.17 | 78.06 | 66.64 | 55.58 | 46.07 |
| Revenue From Operations / Share (Rs.) | 113.83 | 105.61 | 107.00 | 88.02 | 68.67 |
| PBDIT / Share (Rs.) | 20.85 | 20.92 | 17.73 | 13.72 | 10.23 |
| PBIT / Share (Rs.) | 17.65 | 18.40 | 15.52 | 11.43 | 8.01 |
| PBT / Share (Rs.) | 16.68 | 17.59 | 14.53 | 11.06 | 6.15 |
| Net Profit / Share (Rs.) | 12.73 | 13.48 | 11.10 | 9.27 | 4.81 |
| NP After MI And SOA / Share (Rs.) | 13.35 | 13.88 | 11.46 | 9.54 | 4.90 |
| PBDIT Margin (%) | 18.31 | 19.80 | 16.56 | 15.58 | 14.90 |
| PBIT Margin (%) | 15.50 | 17.42 | 14.50 | 12.98 | 11.66 |
| PBT Margin (%) | 14.65 | 16.65 | 13.57 | 12.56 | 8.95 |
| Net Profit Margin (%) | 11.18 | 12.76 | 10.36 | 10.52 | 7.00 |
| NP After MI And SOA Margin (%) | 11.72 | 13.14 | 10.71 | 10.83 | 7.13 |
| Return on Networth / Equity (%) | 14.80 | 17.81 | 17.24 | 17.19 | 10.65 |
| Return on Capital Employeed (%) | 17.64 | 20.69 | 19.93 | 17.13 | 13.63 |
| Return On Assets (%) | 10.86 | 12.73 | 11.34 | 10.61 | 5.74 |
| Long Term Debt / Equity (X) | 0.05 | 0.08 | 0.09 | 0.11 | 0.16 |
| Total Debt / Equity (X) | 0.12 | 0.12 | 0.17 | 0.21 | 0.30 |
| Asset Turnover Ratio (%) | 0.98 | 1.01 | 0.93 | 0.87 | 0.66 |
| Current Ratio (X) | 2.85 | 2.90 | 2.47 | 2.25 | 1.72 |
| Quick Ratio (X) | 1.44 | 1.46 | 1.21 | 1.12 | 0.89 |
| Inventory Turnover Ratio (X) | 3.71 | 1.83 | 2.10 | 2.21 | 1.76 |
| Dividend Payout Ratio (NP) (%) | 20.56 | 17.97 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 16.58 | 15.20 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 79.44 | 82.03 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 83.42 | 84.80 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 21.54 | 25.78 | 17.89 | 9.87 | 5.49 |
| Interest Coverage Ratio (Post Tax) (X) | 14.15 | 17.61 | 12.19 | 6.93 | 3.66 |
| Enterprise Value (Cr.) | 10337.20 | 9856.70 | 6737.01 | 4313.04 | 1318.53 |
| EV / Net Operating Revenue (X) | 2.98 | 3.06 | 2.06 | 1.60 | 0.62 |
| EV / EBITDA (X) | 16.24 | 15.43 | 12.44 | 10.30 | 4.22 |
| MarketCap / Net Operating Revenue (X) | 2.96 | 3.01 | 2.00 | 1.53 | 0.48 |
| Retention Ratios (%) | 79.43 | 82.02 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 3.73 | 4.09 | 3.22 | 2.43 | 0.72 |
| Price / Net Operating Revenue (X) | 2.96 | 3.01 | 2.00 | 1.53 | 0.48 |
| EarningsYield | 0.03 | 0.04 | 0.05 | 0.07 | 0.14 |
After reviewing the key financial ratios for Usha Martin Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 13.37. This value is within the healthy range. It has decreased from 13.92 (Mar 24) to 13.37, marking a decrease of 0.55.
- For Diluted EPS (Rs.), as of Mar 25, the value is 13.37. This value is within the healthy range. It has decreased from 13.92 (Mar 24) to 13.37, marking a decrease of 0.55.
- For Cash EPS (Rs.), as of Mar 25, the value is 15.94. This value is within the healthy range. It has decreased from 16.00 (Mar 24) to 15.94, marking a decrease of 0.06.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 90.17. It has increased from 78.06 (Mar 24) to 90.17, marking an increase of 12.11.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 90.17. It has increased from 78.06 (Mar 24) to 90.17, marking an increase of 12.11.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 113.83. It has increased from 105.61 (Mar 24) to 113.83, marking an increase of 8.22.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 20.85. This value is within the healthy range. It has decreased from 20.92 (Mar 24) to 20.85, marking a decrease of 0.07.
- For PBIT / Share (Rs.), as of Mar 25, the value is 17.65. This value is within the healthy range. It has decreased from 18.40 (Mar 24) to 17.65, marking a decrease of 0.75.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.68. This value is within the healthy range. It has decreased from 17.59 (Mar 24) to 16.68, marking a decrease of 0.91.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.73. This value is within the healthy range. It has decreased from 13.48 (Mar 24) to 12.73, marking a decrease of 0.75.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 13.35. This value is within the healthy range. It has decreased from 13.88 (Mar 24) to 13.35, marking a decrease of 0.53.
- For PBDIT Margin (%), as of Mar 25, the value is 18.31. This value is within the healthy range. It has decreased from 19.80 (Mar 24) to 18.31, marking a decrease of 1.49.
- For PBIT Margin (%), as of Mar 25, the value is 15.50. This value is within the healthy range. It has decreased from 17.42 (Mar 24) to 15.50, marking a decrease of 1.92.
- For PBT Margin (%), as of Mar 25, the value is 14.65. This value is within the healthy range. It has decreased from 16.65 (Mar 24) to 14.65, marking a decrease of 2.00.
- For Net Profit Margin (%), as of Mar 25, the value is 11.18. This value exceeds the healthy maximum of 10. It has decreased from 12.76 (Mar 24) to 11.18, marking a decrease of 1.58.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.72. This value is within the healthy range. It has decreased from 13.14 (Mar 24) to 11.72, marking a decrease of 1.42.
- For Return on Networth / Equity (%), as of Mar 25, the value is 14.80. This value is below the healthy minimum of 15. It has decreased from 17.81 (Mar 24) to 14.80, marking a decrease of 3.01.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.64. This value is within the healthy range. It has decreased from 20.69 (Mar 24) to 17.64, marking a decrease of 3.05.
- For Return On Assets (%), as of Mar 25, the value is 10.86. This value is within the healthy range. It has decreased from 12.73 (Mar 24) to 10.86, marking a decrease of 1.87.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.08 (Mar 24) to 0.05, marking a decrease of 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.12. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.12.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.01 (Mar 24) to 0.98, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 2.85. This value is within the healthy range. It has decreased from 2.90 (Mar 24) to 2.85, marking a decrease of 0.05.
- For Quick Ratio (X), as of Mar 25, the value is 1.44. This value is within the healthy range. It has decreased from 1.46 (Mar 24) to 1.44, marking a decrease of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.71. This value is below the healthy minimum of 4. It has increased from 1.83 (Mar 24) to 3.71, marking an increase of 1.88.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.56. This value is within the healthy range. It has increased from 17.97 (Mar 24) to 20.56, marking an increase of 2.59.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 16.58. This value is below the healthy minimum of 20. It has increased from 15.20 (Mar 24) to 16.58, marking an increase of 1.38.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.44. This value exceeds the healthy maximum of 70. It has decreased from 82.03 (Mar 24) to 79.44, marking a decrease of 2.59.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 83.42. This value exceeds the healthy maximum of 70. It has decreased from 84.80 (Mar 24) to 83.42, marking a decrease of 1.38.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 21.54. This value is within the healthy range. It has decreased from 25.78 (Mar 24) to 21.54, marking a decrease of 4.24.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 14.15. This value is within the healthy range. It has decreased from 17.61 (Mar 24) to 14.15, marking a decrease of 3.46.
- For Enterprise Value (Cr.), as of Mar 25, the value is 10,337.20. It has increased from 9,856.70 (Mar 24) to 10,337.20, marking an increase of 480.50.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.98. This value is within the healthy range. It has decreased from 3.06 (Mar 24) to 2.98, marking a decrease of 0.08.
- For EV / EBITDA (X), as of Mar 25, the value is 16.24. This value exceeds the healthy maximum of 15. It has increased from 15.43 (Mar 24) to 16.24, marking an increase of 0.81.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.96. This value is within the healthy range. It has decreased from 3.01 (Mar 24) to 2.96, marking a decrease of 0.05.
- For Retention Ratios (%), as of Mar 25, the value is 79.43. This value exceeds the healthy maximum of 70. It has decreased from 82.02 (Mar 24) to 79.43, marking a decrease of 2.59.
- For Price / BV (X), as of Mar 25, the value is 3.73. This value exceeds the healthy maximum of 3. It has decreased from 4.09 (Mar 24) to 3.73, marking a decrease of 0.36.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.96. This value is within the healthy range. It has decreased from 3.01 (Mar 24) to 2.96, marking a decrease of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.03, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Usha Martin Ltd:
- Net Profit Margin: 11.18%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.64% (Industry Average ROCE: 13.27%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.8% (Industry Average ROE: 192.3%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 14.15
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 29.7 (Industry average Stock P/E: 101.7)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.12
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.18%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Steel - Alloys/Special | 2A, Shakespeare Sarani, Kolkata West Bengal 700071 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vijay Singh Bapna | Chairman & Ind.Director |
| Mr. Rajeev Jhawar | Managing Director |
| Mr. S B N Sharma | Whole Time Director |
| Mr. Chirantan Chatterjee | Whole Time Director |
| Mr. V Ramakrishna Iyer | Independent Director |
| Mr. Sethurathnam Ravi | Independent Director |
| Mrs. Ramni Nirula | Independent Director |
FAQ
What is the intrinsic value of Usha Martin Ltd?
Usha Martin Ltd's intrinsic value (as of 10 February 2026) is ₹392.66 which is 10.15% lower the current market price of ₹437.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹13,307 Cr. market cap, FY2025-2026 high/low of ₹498/279, reserves of ₹2,934 Cr, and liabilities of ₹3,854 Cr.
What is the Market Cap of Usha Martin Ltd?
The Market Cap of Usha Martin Ltd is 13,307 Cr..
What is the current Stock Price of Usha Martin Ltd as on 10 February 2026?
The current stock price of Usha Martin Ltd as on 10 February 2026 is ₹437.
What is the High / Low of Usha Martin Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Usha Martin Ltd stocks is ₹498/279.
What is the Stock P/E of Usha Martin Ltd?
The Stock P/E of Usha Martin Ltd is 29.7.
What is the Book Value of Usha Martin Ltd?
The Book Value of Usha Martin Ltd is 97.3.
What is the Dividend Yield of Usha Martin Ltd?
The Dividend Yield of Usha Martin Ltd is 0.69 %.
What is the ROCE of Usha Martin Ltd?
The ROCE of Usha Martin Ltd is 18.8 %.
What is the ROE of Usha Martin Ltd?
The ROE of Usha Martin Ltd is 15.8 %.
What is the Face Value of Usha Martin Ltd?
The Face Value of Usha Martin Ltd is 1.00.